Atlas Trials

Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China

Clinical trial NCT01044316 · COMPLETED

Trial details

NCT number
NCT01044316
Sponsor
Novartis Vaccines
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Haemophilus Influenzae Type b (Hib) Infection
Start date
2010-04-01
Primary completion
2010-07-01
Enrollment
670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.